Inhibition of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced lymphoma formation by oltipraz

Cancer Research

Volumn 56, Issue 15, 1996, Pages 3395-3398

  Rao, Chinthalapally V ^a   Rivenson, Abraham ^a   Zang, Edith ^a   Steele, Vernon ^b   Kelloff, Gary ^b   Reddy, Bandaru S ^a  

^a AMERICAN HEALTH FOUNDATION   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE; OLTIPRAZ;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CANCER INCIDENCE; CONTROLLED STUDY; DOSE RESPONSE; LYMPHOMA; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SURVIVAL RATE; THYMOMA; WEIGHT GAIN;

ANIMALS; ANTICARCINOGENIC AGENTS; BODY WEIGHT; CARCINOGENS; IMIDAZOLES; INTESTINAL NEOPLASMS; LYMPHOMA; MALE; PYRAZINES; RATS; RATS, INBRED F344;

EID: 0029682493     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Parker, S. L., Tong, T. Bolden, S., and Wingo, P. A. Cancer statistics, 1996. CA Cancer J. Clin., 46: 5-27, 1996.
2. Devesa, S. S., and Fears, T. Non-Hodgkin's lymphoma time trends United States and international data. Cancer Res , 52: 5432s-5440s, 1992.
3. Davis, S. Nutritional factors and the development of non-Hodgkin's lymphoma: a review of the evidence. Cancer Res., 52: 5492s-5495s, 1992.
4. Franceschi, S., Serraino, D., Carbone, A., Talamini, R., and Vecchia, C. L. Dietary factors and non-Hodgkin's lymphoma: a case control study in the northeastern part of Italy. Nutr. Cancer, 12: 333-341, 1989.
5. Brown, L. M., Everett, G. D., Gibson, R., Burmeister, L. F., Schuman, L. M., and Blair, A. Smoking and risk of non-Hodgkin's lymphoma and multiple myeloma. Cancer Causes Control, 3: 49-55, 1992.
6. Linet, M. S., McLaughlin, J. K., Hsing, A. W., Wacholder, S., Chien, H. T., Schuman, L. M., Bjelke, E., and Bolt, W. J. Is cigarette smoking a risk factor for non-Hodgkin's lymphoma or multiple myeloma? Results from the Lutheran brotherhood cohort study. Leukemia Res., 16: 621-624, 1992.
7. Sugimura, T., Wakabayashi, K., Nagao, M., and Esumi, H. A new class of carcinogens: heterocyclic amines in cooked food. In: D. V. Parke, C. Ioannides and R. Walker (eds.), Food, Nutrition and Chemical Toxicity, pp. 259-276. London, Smith-Gordon, 1993.
8. Layton, D. W., Bogen, K. T., Knize, M. G. Hatch, F. T., Johnson, V. M., and Felton, J. S. Cancer risk of heterocyclic amines in cooked foods: an analysis and implications for research. Carcinogenesis (Lond.), 16: 39-52, 1995.
9. Esumi, H., Ohgaki, H., Kohzen, E., Takayama, S., and Sugimura, T. Induction of lymphoma in CDF1 mice by the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Jpn. J. Cancer Res., 80: 1176-1178, 1989.
10. Wattenberg, L. W. Chemoprevention of cancer by naturally occurring and synthetic compounds. In: L. W. Wattenberg, M. Lipkin, C. W. Boone, and G. J. Kelloff (eds.), Cancer Chemoprevention, pp 19-39. Boca Raton, FL: CRC Press, 1992.
11. Steele, V. E., Moon, R. C., Lubet, R. A., Grubbs, C. J., Reddy, B. S., Wargovich, M. J., McCormick, D. L., Pereira, M. A., Crowell, J. A., Bagheri, D., Sigma, C. C., Boone, C. W., and Kelloff, G. J. Preclinical efficacy evaluation of potential chemopreventive agents in animal carcinogenesis models: methods and results from the NCI chemopreventive drug development program. J. Cell. Biochem. Suppl., 20: 32-54, 1994.
12. Kensler, T. W., Groopman, J. D., and Roebuck, B. D. chemoprotection by oltipraz and other dithiolethiones In: L. W. Wattenberg, M. Lipkin, C. W. Boone, and G. J. Kelloff (eds.), Cancer Chemoprevention, pp. 205-226. Boca Raton, FL CRC Press, 1992.
13. Rao, C. V., Rivenson, A., Katiwalla, M., Kelloff, G. J., and Reddy, B. S. Chemopreventive effect of oltipraz during different stages of experimental colon carcinogenesis induced by azoxymethane in male F344 rats. Cancer Res., 53: 2502-2506, 1993.
14. Lin, D-X., Lang, N. P., and Kadlubar, F. F. Species differences in the biotransformation of the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by hepatic microsomes and cytosols from humans, rats, and mice. Drug Metab. Dispos., 23: 518-524, 1995.
15. Rao, C. V., Tokumo, K., Rigotty, Zang, E., Kelloff, G., and Reddy, B. S. Chemoprevention of colon carcinogenesis by dietary administration of piroxicam, α-difluoromethylornithine, 16α-fluoro-5-androsten-17-one, and ellagic acid individually and in combination Cancer Res., 51: 4528-4534, 1991.
16. Rao, C. V., Tokumo, K., Kelloff, G. J., and Reddy, B. S. Inhibition of dietary oltipraz of experimental intestinal carcinogenesis induced by azoxymethane in male F344 rats. Carcinogenesis (Lond.), 12: 1051-1055, 1991.
17. Ogiu, T., Fukami, H., Nishimura, M., Shimada, Y., and Maekawa, A. Age-dependent induction of thymic lymphomas by N-propyl-N-nitrosourea in the F344/DuCrj rat. Thymus, 20: 249-258, 1992.
18. Evans, A. S., and Muller, N. E. Viruses and cancer: causal associations. Ann. Epidemiol., 1: 71-92, 1990.
19. Morgenthaler, P-M. L., and Holzhauser, D. Analysis of mutations induced by 2-a-mino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in human lymphoblastoid cells. Carcinogenesis (Lond.), 16: 713-718, 1995.
20. Rivenson, A., Rao, C. V., Steele, V., Kelloff, G., and Reddy, B. S. Inhibition of 2-amino-1-methyl-6-phenylimidazo[4,5-β]pyridine (PhIP)-induced lymphoma by oltipraz in rats. FASEB J., 9: A139, 1995.